Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Micrococcus spp. as a promising source for drug discovery: A review
Daniela Tizabi1, Russell T Hill1
1Institute of Marine and Environmental Technology, University of Maryland Center for Environmental Science, Baltimore, MD 21202, USA.
Micrococcus bacteria, often overlooked for drug discovery due to small genomes, possess significant bioactive potential. Re-examining these strains, especially marine isolates, is crucial for identifying novel pharmaceutical compounds.
Area of Science:
- Microbiology
- Drug Discovery
- Natural Products Chemistry
Background:
- Actinobacteria are a rich source of bioactive compounds.
- The genus Micrococcus is under-explored for drug discovery.
- Small genomes in Micrococcus limit detection by current mining algorithms.
Conclusions:
- The Micrococcus genus possesses considerable, yet largely untapped, biosynthetic potential.
- Further investigation into Micrococcus, especially marine strains, is warranted for novel drug discovery.
- Developing new methods to explore small-genome bacteria could unlock new bioactive compounds.
More Related Videos
10:19Establishment and Optimization of a High Throughput Setup to Study Staphylococcus epidermidis and Mycobacterium marinum Infection as a Model for Drug Discovery
Published on: June 26, 2014
05:40Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally
Published on: April 25, 2025
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Synthetic Biology
Golden rice
Golden rice is a genetically modified...